Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.
Kohteen Merck & Co Inc nykyinen hinta markkinoilla on 129,98 €, ja sen 24 tunnin kaupankäyntivolyymi on 798,54M €. Omaisuuserän markkina-arvo on 320,68B € sen muututtua 0.54% viimeisen päivän aikana.
Tokenisoidun Merck & Co Inc kaupankäyntihinta on 131,99 €, sen tokenisoitu markkina-arvo on 248,57K € ja 24 tunnin kaupankäyntivolyymi on 134,62K €. Tokenisoitu omaisuuserä on liikkunut -0.76% viimeisen 24 tunnin aikana.